| Derrick Alan Montgomery, MD | |
|
316th Mdg, 1060 W. Perimeter Rd Suite 3k43, Andrews Afb, MD 20762 | |
| (240) 612-1730 | |
| Not Available |
| Full Name | Derrick Alan Montgomery |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology - Cornea And External Diseases Specialist |
| Location | 316th Mdg, Andrews Afb, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225133499 | NPI | - | NPPES |
| Entity Name | Southern Ohio Eye Surgical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447286059 PECOS PAC ID: 0446223382 Enrollment ID: O20040818000365 |
News Archive
Using proton pump inhibitors and antiplatelet drugs (thienopyridines) together is an appropriate way of treating patients with cardiovascular disease who are at high risk of upper gastrointestinal bleeds, despite recent concerns about an adverse interaction between these two types of drugs, according to an Expert Consensus Document released jointly today by the American College of Cardiology Foundation, the American College of Gastroenterology, and the American Heart Association.
In a Guest Editorial published in the new publication Clinical Investigation, Dr Jeffrey Weitz and Dr John Eikelboom of McMaster University in Hamilton, Canada highlight the importance of the approval in October by the FDA of dabigatran etexilate (Pradaxa®; Boehringer Ingelheim). This new oral thrombin inhibitor provides an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.
In view of current events on mainland China, The Centre for Health Protection's, Dr P Y Leung, today (April 27) called a meeting with representatives of the Department of Health (DH), Hospital Authority and universities to review laboratory safety procedures in Hong Kong.
The Center for Strategic & International Studies' "Smart Global Health" blog provides a brief tutorial on accessing the center's "Global Health Policy in the Second Obama Term" iTunes University course on a mobile device as well as through iTunes (4/11).
Alere Inc., a global leader in rapid diagnostics announced today the completion of the previously announced sale of its BBI business to Exponent Private Equity LLP, a UK-based private equity firm. BBI Group provides products and services for the diagnostic, healthcare, research, defense and food industries globally.
› Verified 8 days ago
| Entity Name | Patrick L Spencer Do, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922051168 PECOS PAC ID: 0648322537 Enrollment ID: O20090724000076 |
News Archive
Using proton pump inhibitors and antiplatelet drugs (thienopyridines) together is an appropriate way of treating patients with cardiovascular disease who are at high risk of upper gastrointestinal bleeds, despite recent concerns about an adverse interaction between these two types of drugs, according to an Expert Consensus Document released jointly today by the American College of Cardiology Foundation, the American College of Gastroenterology, and the American Heart Association.
In a Guest Editorial published in the new publication Clinical Investigation, Dr Jeffrey Weitz and Dr John Eikelboom of McMaster University in Hamilton, Canada highlight the importance of the approval in October by the FDA of dabigatran etexilate (Pradaxa®; Boehringer Ingelheim). This new oral thrombin inhibitor provides an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.
In view of current events on mainland China, The Centre for Health Protection's, Dr P Y Leung, today (April 27) called a meeting with representatives of the Department of Health (DH), Hospital Authority and universities to review laboratory safety procedures in Hong Kong.
The Center for Strategic & International Studies' "Smart Global Health" blog provides a brief tutorial on accessing the center's "Global Health Policy in the Second Obama Term" iTunes University course on a mobile device as well as through iTunes (4/11).
Alere Inc., a global leader in rapid diagnostics announced today the completion of the previously announced sale of its BBI business to Exponent Private Equity LLP, a UK-based private equity firm. BBI Group provides products and services for the diagnostic, healthcare, research, defense and food industries globally.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Derrick Alan Montgomery, MD 316th Mdg, 1060 W. Perimeter Rd Suite 3k43, Andrews Afb, MD 20762 Ph: (240) 612-1730 | Derrick Alan Montgomery, MD 316th Mdg, 1060 W. Perimeter Rd Suite 3k43, Andrews Afb, MD 20762 Ph: (240) 612-1730 |
News Archive
Using proton pump inhibitors and antiplatelet drugs (thienopyridines) together is an appropriate way of treating patients with cardiovascular disease who are at high risk of upper gastrointestinal bleeds, despite recent concerns about an adverse interaction between these two types of drugs, according to an Expert Consensus Document released jointly today by the American College of Cardiology Foundation, the American College of Gastroenterology, and the American Heart Association.
In a Guest Editorial published in the new publication Clinical Investigation, Dr Jeffrey Weitz and Dr John Eikelboom of McMaster University in Hamilton, Canada highlight the importance of the approval in October by the FDA of dabigatran etexilate (Pradaxa®; Boehringer Ingelheim). This new oral thrombin inhibitor provides an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.
In view of current events on mainland China, The Centre for Health Protection's, Dr P Y Leung, today (April 27) called a meeting with representatives of the Department of Health (DH), Hospital Authority and universities to review laboratory safety procedures in Hong Kong.
The Center for Strategic & International Studies' "Smart Global Health" blog provides a brief tutorial on accessing the center's "Global Health Policy in the Second Obama Term" iTunes University course on a mobile device as well as through iTunes (4/11).
Alere Inc., a global leader in rapid diagnostics announced today the completion of the previously announced sale of its BBI business to Exponent Private Equity LLP, a UK-based private equity firm. BBI Group provides products and services for the diagnostic, healthcare, research, defense and food industries globally.
› Verified 8 days ago